United States · FDA National Drug Code directory
Fludeoxyglucose F 18
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67939-010_d93db56f-430e-5490-e053-2995a90ace22
- Product NDC
- 67939-010
- Form
- INJECTION
- Composition / generic term
- Fludeoxyglucose F 18
- Labeler
- The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20131101
- Source listing expiry
- 20261231
Source-listed ingredients
- FLUDEOXYGLUCOSE F-18 — 300 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 50 mL in 1 VIAL, MULTI-DOSE (67939-010-50) · 67939-010-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →